NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression – The debate continues

por Mushtaq, Kamran, Khan, Muhammad Umair, Iqbal, Fatima, Alsoub, Deema Hussam, Chaudhry, Hammad Shabir, Ata, Fateen, Iqbal, Phool, Elfert, Khaled, Balaraju, Girisha, Almaslamani, Muna, Al-Ejji, Khalid, AlKaabi, Saad, Kamel, Yasser Medhat
Publicado 2021

Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipients

por Webb, Gwilym J., Moon, Andrew M., Barnes, Eleanor, Barritt, A. Sidney, Marjot, Thomas
Publicado 2021

EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients

por Cornberg, Markus, Buti, Maria, Eberhardt, Christiane S., Grossi, Paolo Antonio, Shouval, Daniel
Publicado 2021

Remaining challenges in HCV elimination

por Capraru, Camelia, Feld, Jordan J.
Publicado 2021

Primary biliary cholangitis associated with SARS-CoV-2 infection

por Bartoli, Alessandra, Gitto, Stefano, Sighinolfi, Pamela, Cursaro, Carmela, Andreone, Pietro
Publicado 2021

Intravenous ketamine and progressive cholangiopathy in COVID-19 patients

Publicado 2021

Progressive cholangiopathy in COVID-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered

por Deltenre, Pierre, Moreno, Christophe, Trépo, Eric
Publicado 2021

Let’s leverage SARS-CoV2 vaccination to screen for hepatitis C in Spain, in Europe, around the world

por Crespo, Javier, Lazarus, Jeffrey V., Iruzubieta, Paula, García, Federico, García-Samaniego, Javier
Publicado 2021

Reply to: “Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipients”

por Rodríguez-Perálvarez, Manuel, Colmenero, Jordi, Salcedo, Magdalena
Publicado 2021

Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?

por Bril, Fernando, Al Diffalha, Sameer, Dean, Mark, Fettig, David M.
Publicado 2021

Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients

por Rabinowich, Liane, Grupper, Ayelet, Baruch, Roni, Ben-Yehoyada, Merav, Halperin, Tami, Turner, Dan, Katchman, Eugene, Levi, Sharon, Houri, Inbal, Lubezky, Nir, Shibolet, Oren, Katchman, Helena
Publicado 2021

Risk stratification in hospitalized COVID-19 patients

por Horvath, Angela, Lind, Theresa, Frece, Natalie, Wurzer, Herbert, Stadlbauer, Vanessa
Publicado 2021

Comment on “Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?”

por Capecchi, Pier Leopoldo, Lazzerini, Pietro Enea, Brillanti, Stefano
Publicado 2021

HCV detection is possible during SARS CoV-2 testing; and throughout COVID-19 vaccination?

por Crespo, Javier, Díaz-González, Álvaro, Cabezas, Joaquín
Publicado 2021

From the Editor’s Desk…

por Burra, Patrizia, Tacke, Frank, Ratziu, Vlad, Zeuzem, Stefan, Sangro, Bruno, Angeli, Paolo
Publicado 2021

Protected or not protected, that is the question - First data on COVID-19 vaccine responses in patients with NAFLD and liver transplant recipients

por Cornberg, Markus, Eberhardt, Christiane S.
Publicado 2021

High acceptance rate of COVID-19 vaccination in liver transplant recipients

por Giannini, Edoardo G., Marenco, Simona
Publicado 2021

Reply to: Comments on “Association of liver abnormalities with in-hospital mortality in patients with COVID-19”

por Ding, Ze-yang, Li, Gan-xun, Shu, Chang, Yin, Ping, Zhang, Bixiang
Publicado 2021

Safety and immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (CHESS2101): A multicenter study

por Wang, Jitao, Hou, Zhiyun, Liu, Jianxin, Gu, Ye, Wu, Yunhong, Chen, Zhenhuai, Ji, Jiansong, Diao, Shiqi, Qiu, Yuanwang, Zou, Shengqiang, Zhang, Aiguo, Zhang, Nina, Wang, Fengxian, Li, Xue, Wang, Yan, Liu, Xing, Lv, Cheng, Chen, Shubo, Liu, Dengxiang, Ji, Xiaolin, Liu, Chao, Ren, Tao, Sun, Jingwei, Zhao, Zhongwei, Wu, Fazong, Li, Fenxiang, Wang, Ruixu, Yan, Yan, Zhang, Shiliang, Ge, Guohong, Shao, Jiangbo, Yang, Shiying, Liu, Chuan, Huang, Yifei, Xu, Dan, Li, Xiaoguo, Ai, Jingwen, He, Qing, Zheng, Ming-Hua, Zhang, Liting, Xie, Qing, Rockey, Don C., Fallowfield, Jonathan A., Zhang, Wenhong, Qi, Xiaolong
Publicado 2021

Autoimmune hepatitis following SARS-CoV-2 vaccine: May not be a casuality

por Rocco, Alba, Sgamato, Costantino, Compare, Debora, Nardone, Gerardo
Publicado 2021